NS 1738

CAS No. 501684-93-1

NS 1738 ( NSC 213859 )

Catalog No. M21151 CAS No. 501684-93-1

NS 1738 is a positive allosteric modulator of the α7-containing neuronal nicotinic acetylcholine receptors (nAChRs).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 76 Get Quote
25MG 155 Get Quote
50MG 264 Get Quote
100MG 447 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NS 1738
  • Note
    Research use only not for human use.
  • Brief Description
    NS 1738 is a positive allosteric modulator of the α7-containing neuronal nicotinic acetylcholine receptors (nAChRs).
  • Description
    NS 1738 is a positive allosteric modulator of the α7-containing neuronal nicotinic acetylcholine receptors (nAChRs).
  • Synonyms
    NSC 213859
  • Pathway
    Endocrinology/Hormones
  • Target
    AChR
  • Recptor
    nAChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    501684-93-1
  • Formula Weight
    365.14
  • Molecular Formula
    C14H9Cl2F3N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:300 mg/mL (821.63 mM)
  • SMILES
    O=C(Nc1cc(Cl)ccc1O)Nc1cc(C(F)(F)F)ccc1Cl
  • Chemical Name
    3-(5-chloro-2-hydroxyphenyl)-1-[2-chloro-5-(trifluoromethyl)phenyl]urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Timmermann D B Gronlien J H Kohlhaas K L et al. An Allosteric Modulator of the 7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo[J]. Journal of Pharmacology and Experimental Therapeutics 2007 323(1):294-307.
molnova catalog
related products
  • Tacrine

    Tacrine is an indirect cholinergic agonist and centrally acting anticholinesterase.

  • Gabapentin

    Gabapentin (brand name Neurontin) is a medication originally developed for the treatment of epilepsy.

  • Edrophonium chloride

    Edrophonium chloride is an acetylcholinesterase (AChE) inhibitor that is known to prevent the breakdown of the neurotransmitter acetylcholine by binding specifically to its catalytic site.